Howard Gurney

15PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPacific Peoples cultural determinants of healthSensory processes, perception and performance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 02, 2025
Psychosocial factors associated with perceived cognitive functioning in prostate cancer survivors: an exploratory cross-sectional analysis.

Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon

|Mar 05, 2025
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.

Daniel P Petrylak, Raffaele Ratta, Nobuaki Matsubara

|Jan 18, 2025
BRCA Mutation Testing in Men With Metastatic Castration-Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice.

Arun A Azad, Howard Gurney, Ainsley Campbell

|Jan 15, 2025
Perceived cognitive impairment and occupational functioning in prostate cancer survivors: an exploratory cross-sectional analysis.

Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon

|Jul 22, 2024
What is the nature and impact of cognitive difficulties following hormonal treatments for prostate cancer?: An interpretative phenomenological analysis.

Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon

|Jan 16, 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

Robert J Motzer, Camillo Porta, Masatoshi Eto

Pageof 3

Frequent Collaborators

3 joint publications

Heather Francis

3 joint publications

Thomas Powles

3 joint publications

Lorna Pembroke

3 joint publications

David Gillatt